One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines

The changing epidemiology of human monkeypox—A potential threat? A systematic review

(2022) Eveline M. Bunge et al.   PLoS Neglected Tropical Diseases

Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022

(2022) Fuminari Miura et al.   Eurosurveillance

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022

(2022) John P. Thornhill et al.   NEW ENGLAND JOURNAL OF MEDICINE

A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS

(2020) Edgar Turner Overton et al.   VACCINE

Persistence of HB sAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults

(2019) Pierre Van Damme et al.   JOURNAL OF VIRAL HEPATITIS

Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox

(2019) Phillip R. Pittman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial

(2018) Edgar Turner Overton et al.   PLoS One

Emergence of Monkeypox — West and Central Africa, 1970–2017

(2018) Kara N. Durski et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Two cases of monkeypox imported to the United Kingdom, September 2018

(2018) Aisling Vaughan et al.   Eurosurveillance

Non-Neutralizing Antibodies Directed against HIV and Their Functions

(2017) Luzia M. Mayr et al.   Frontiers in Immunology

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

(2016) Carole J. Henry Dunand et al.   Cell Host & Microbe

British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015

(2016) Anna Maria Geretti et al.   HIV MEDICINE

Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses — Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015

(2016) Brett W. Petersen et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects

(2016) Richard N. Greenberg et al.   PLoS One

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

(2015) Sharon E. Frey et al.   VACCINE

Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial

(2015) E. T. Overton et al.   Open Forum Infectious Diseases

Cardiac Safety of Modified Vaccinia Ankara for Vaccination against Smallpox in a Young, Healthy Study Population

(2015) Eva-Maria Zitzmann-Roth et al.   PLoS One

A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis

(2015) Richard N Greenberg et al.   PLoS One

Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

(2014) Lorry G. Rubin et al.   CLINICAL INFECTIOUS DISEASES

Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis

(2014) Frank von Sonnenburg et al.   VACCINE

Phase II randomized, double-blinded comparison of a single high dose (5×108 TCID50) of modified vaccinia Ankara compared to a standard dose (1×108 TCID50) in healthy vaccinia-naïve individuals

(2014) Sharon E. Frey et al.   VACCINE

The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy

(2014) Masoomeh Bagheri-Jamebozorgi et al.   Human Vaccines & Immunotherapeutics

Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial

(2013) Stephen R. Walsh et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario

(2013) Sharon E. Frey et al.   VACCINE

Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects

(2012) R. N. Greenberg et al.   JOURNAL OF INFECTIOUS DISEASES

Countermeasures and vaccination against terrorism using smallpox: pre-event and post-event smallpox vaccination and its contraindications

(2010) Hajime Sato   Environmental Health and Preventive Medicine

Evaluation of smallpox vaccines using variola neutralization

(2009) I. K. Damon et al.   JOURNAL OF GENERAL VIROLOGY

Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain

(2009) Mark Suter et al.   VACCINE

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®

(2009) Alfred von Krempelhuber et al.   VACCINE

Vaccines: Correlates of Vaccine‐Induced Immunity

(2008) Stanley A. Plotkin   CLINICAL INFECTIOUS DISEASES

Determination of the appropriate quarantine period following smallpox exposure: An objective approach using the incubation period distribution

(2008) Hiroshi Nishiura   INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH

Long‐Term Persistence of Mumps Antibody after Receipt of 2 Measles‐Mumps‐Rubella (MMR) Vaccinations and Antibody Response after a Third MMR Vaccination among a University Population

(2008) Anand A. Date et al.   JOURNAL OF INFECTIOUS DISEASES

Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus

(2008) P. L. Earl et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA